Park Avenue Securities LLC Charles River Laboratories International, Inc. Transaction History

Park Avenue Securities LLC

$9.72 Billion
Q4 2024

A detailed history of Park Avenue Securities LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 2,785 shares of CRL stock, worth $454,010. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,785

Previous 3,344 16.72%

Holding current value

$454,010

Previous $659,000 22.0%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$178.58 - $220.69 $99,826 - $123,365	-559 Reduced 16.72%	2,785 $514,000
Q3 2024 Oct 03, 2024	SELL	$187.96 - $245.29 $104,693 - $136,626	-557 Reduced 14.28%	3,344 $659,000
Q2 2024 Jul 09, 2024	BUY	$206.39 - $268.73 $17,749 - $23,110	86 Added 2.25%	3,901 $806,000
Q1 2024 Apr 10, 2024	BUY	$203.52 - $273.43 $41,314 - $55,506	203 Added 5.62%	3,815 $1.03 Million
Q4 2023 Jan 10, 2024	SELL	$164.52 - $238.84 $73,375 - $106,522	-446 Reduced 10.99%	3,612 $854,000
Q3 2023 Oct 26, 2023	BUY	$194.44 - $217.61 $789,037 - $883,061	4,058 New	4,058 $795,000
Q4 2022 Jan 24, 2023	BUY	$197.11 - $250.07 $54,599 - $69,269	277 Added 7.81%	3,825 $0
Q3 2022 Nov 01, 2022	SELL	$182.44 - $250.54 $871,151 - $1.2 Million	-4,775 Reduced 57.37%	3,548 $698,000
Q2 2022 Jul 27, 2022	SELL	$204.13 - $302.4 $47,154 - $69,854	-231 Reduced 2.7%	8,323 $1.78 Million
Q1 2022 Apr 29, 2022	BUY	$255.51 - $362.11 $489,557 - $693,802	1,916 Added 28.86%	8,554 $2.43 Million
Q4 2021 Apr 08, 2022	BUY	$351.38 - $448.68 $138,443 - $176,779	394 Added 6.31%	6,638 $2.5 Million
Q3 2021 Oct 21, 2021	BUY	$372.64 - $458.3 $10,061 - $12,374	27 Added 0.43%	6,244 $2.58 Million
Q2 2021 Aug 05, 2021	BUY	$294.17 - $371.65 $130,023 - $164,269	442 Added 7.65%	6,217 $2.3 Million
Q1 2021 Apr 28, 2021	BUY	$249.67 - $299.48 $138,816 - $166,510	556 Added 10.65%	5,775 $1.67 Million
Q4 2020 Jan 20, 2021	BUY	$222.0 - $252.62 $31,302 - $35,619	141 Added 2.78%	5,219 $1.3 Million
Q3 2020 Nov 03, 2020	BUY	$175.56 - $226.45 $88,482 - $114,130	504 Added 11.02%	5,078 $1.15 Million
Q2 2020 Jul 30, 2020	BUY	$118.84 - $189.72 $543,574 - $867,779	4,574 New	4,574 $797,000
Q1 2020 Apr 28, 2020	SELL	$98.9 - $178.34 $488,170 - $880,286	-4,936 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$126.05 - $152.76 $35,672 - $43,231	283 Added 6.08%	4,936 $754,000
Q3 2019 Oct 18, 2019	BUY	$125.07 - $143.67 $581,950 - $668,496	4,653 New	4,653 $616,000

Others Institutions Holding CRL

# of Institutions

708

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.29B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Charles River Laboratories International, Inc. Transaction History